Microbiogen is now part of Novonesis, bringing more than two decades of specialist yeast innovation into a global leader in biosolutions. Based in Australia, Microbiogen develops advanced 𝘚𝘢𝘤𝘤𝘩𝘢𝘳𝘰𝘮𝘺𝘤𝘦𝘴 𝘤𝘦𝘳𝘦𝘷𝘪𝘴𝘪𝘢𝘦 strains that help yeast perform better in demanding industrial environments. Our proprietary technology platform and extensive library of elite yeast genetics enable us to combine multiple valuable traits in a single strain, creating robust yeast solutions for industrial applications. Our relationship with Novonesis spans more than a decade and includes the co-development of the Innova® yeast series for the bioethanol industry. Now, as part of Novonesis, we are bringing our complementary expertise together to strengthen yeast innovation and explore its potential across more industries.
Looking for a particular MicroBioGen employee's phone or email?
The MicroBioGen annual revenue was $2.7 billion in 2026.
Geoffrey Bell is the CEO of MicroBioGen.
23 people are employed at MicroBioGen.
MicroBioGen is based in Sydney, New South Wales.
The NAICS codes for MicroBioGen are [31111, 3111, 31, 311].
The SIC codes for MicroBioGen are [20, 204].